malformed heart
human heart context
adult human heart
cardiac diseases
engineered heart tissues
ischemic heart disease
EHT-CaMKII project
CV diseases
cardiac pathologies
EHT-CMs maturation process
cardiac repair
clinical syndrome of heart failure
normal cardiac function
numerous EHT applications
biological role of CaMKII
disease modeling
CV deaths account
immaturity of hiPSC EHTs cardiomyocytes
progressive loss of cardiac contractile function
recent availability of human induced pluripotent stem cells
hiPSCs
isolated CMs
hand
D cultured hiPSC-cardiomyocytes
extent different CaMKII isoforms
maturation enhancement
drug screening
progression of HF
Drug therapy
various pathologies
loss of myocardium
testing drugs
clear advantages
artificial living
host laboratory
help
treatment costs
stimulation
set of indices
interesting impact
European Union
parameter
promising technique
world
myocardial infarction
leading cause of death
mature phenotype
parts
preliminary results
years progress
novel
combination
biology
engineering
curative approach
mortality
Euros
objective
proposal
addition